Mental Training for CFS Following EBV Infection in Adolescents

Status Completed

Clinical Trial Summary

The general aim of this study is to investigate the effect of an individually tailored mental training program in adolescents developing chronic fatigue syndrome (CFS) after an acute Epstein Barr-virus (EBV) infection. Endpoints include physical activity (primary endpoint), symptoms (fatigue, pain, insomnia), cognitive function (executive functions) and markers of disease mechanisms (autonomic, endocrine, and immune responses).

Clinical Trial Description

EBV-infection is a well-known trigger of CFS. A closely related research project (Chronic fatigue following acute Epstein-Barr virus infection in Adolescents; ClinicalTrials ID:NCT02335437) is a combined prospective and cross-sectional study of 200 adolescents suffering from acute EBV infection. The primary aim of that study is to identify factors that predispose to CFS 6 months after the acute infection. Thus, that project will provide a sample of thoroughly characterized CFS patients, all having the same precipitation factor (EBV-infection). The present project is an intervention trial in the subgroup of patients that actually did develop CFS 6 months after the acute EBV infection. Patients will be randomised 1:1 to either a mental training program (10 sessions) combining elements from cognitive behavioral therapy and music therapy, or routine follow-up from the general practitioner. By its nature, treatment group allocation cannot be blinded; however, both patients and therapists will be blinded for end-point evaluation. An extensive investigational program will be carried out at three time points: Prior to the intervention, immediately after the intervention, and 1 year after the intervention. The program includes: Clinical examination; Pain threshold assessment; Cardiovascular assessment; Cognitive assessment; Sampling of biological material (blood and urine); Questionnaire; Brain fMRI; Qualitative interview; Monitoring of physical activity (accelerometer) ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02499302
Study type	Interventional
Source	University Hospital, Akershus
Contact
Status	Completed
Phase	N/A
Start date	October 2015
Completion date	October 2018

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05899595` - Effects of a Personalized Physical Training to Reduce Fatigue	N/A
Not yet recruiting	`NCT01154647` - Pain Inhibition in Patients With Rheumatoid Arthritis and Central Sensitivity Syndromes	N/A
Completed	`NCT00375973` - Double Blind Trial of Duloxetine in Chronic Fatigue Syndrome	Phase 2/Phase 3
Completed	`NCT02156128` - Subjective Memory Complaints, Objective Memory Performance and Cognitive Training	N/A
Not yet recruiting	`NCT06386133` - Chronic Fatigue in Multiple Sclerosis: MS Copilot Boost Solution Compared to Standard Care	N/A
Not yet recruiting	`NCT05116657` - Obstructive Sleep Apnoea Post Covid 19: Role of the Upper Airway Microbiome
Completed	`NCT00788918` - Study of Cerebral Function in Patients With Chronic Hepatitis C Infection (HCV/CNS)	N/A
Completed	`NCT04435002` - The Effect of Acupressure on Fatigue in Individuals With Chronic Fatigue Syndrome	N/A
Recruiting	`NCT05778006` - Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis (ME/CFS) Registry and Biobank, COVID-19, SARS-CoV-2
Recruiting	`NCT06253026` - Fatigue in Air Search and Rescue Missions
Completed	`NCT00001415` - Glucocorticoid Effects on Cellular Cytokine Release	N/A
Completed	`NCT04797871` - Resistance Training and Clinical Status in Patients With Post Discharge Symptoms After Covid-19	N/A
Recruiting	`NCT04049331` - Testosterone Replacement in Male Cancer Survivors With Fatigue and Low Testosterone	Phase 2
Completed	`NCT02335437` - Chronic Fatigue Following Acute Epstein-Barr Virus Infection in Adolescents	N/A
Recruiting	`NCT05728918` - Effectiveness of Antrodia Cinnamomea Mycelia on Improving Immune Response in Subhealth People	N/A
Completed	`NCT04833673` - The Effects of Relaxation Techniques on Pain, Fatigue and Kinesiophobia in Multiple Sclerosis Patients: A Three Arms Randomized Trial	N/A
Recruiting	`NCT04947488` - Evaluation of the Effects of Treatment With Bioarginin C in Adult Subjects Belonging to the Post-Covid Day Hospital	N/A
Recruiting	`NCT05840237` - REGAIN: RCT of Oxaloacetate for Fatigue in Long COVID	N/A
Active, not recruiting	`NCT04104750` - The Assessment of Fatigue and Quality of Life in Patients With Bone Tumor,
Recruiting	`NCT03773003` - Research for Pathophysiology of Cancer Related Fatigue (CRF) and Chronic Fatigue (CFS/ME)	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.